Quantitative radioluminography of serotonin uptake sites in the porcine brain
暂无分享,去创建一个
[1] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[2] C. de Montigny,et al. Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression , 1987, Journal of clinical psychopharmacology.
[3] P. Blier,et al. Modulation of 5‐HT release in the guinea‐pig brain following long‐term administration of antidepressant drugs , 1994, British journal of pharmacology.
[4] P. Sáiz,et al. PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain , 1997, European Neuropsychopharmacology.
[5] S. Snyder,et al. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. , 1987, The Journal of pharmacology and experimental therapeutics.
[6] H. Trenholm,et al. Effect of deoxynivalenol on neurotransmitters in discrete regions of swine brain , 1992, Archives of environmental contamination and toxicology.
[7] P. Plenge,et al. Differences in brain 5-HT transporter dissociation rates among animal species. , 1995, Pharmacology & toxicology.
[8] A. Gjedde,et al. Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain , 1999, European Neuropsychopharmacology.
[9] A. Gjedde,et al. Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain , 1998, Journal of Neuroscience Methods.
[10] U. Scheffel,et al. In Vivo Labeling of Serotonin Uptake Sites with [3H]Paroxetine , 1989, Journal of neurochemistry.
[11] Donald F. Smith. Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and ‘higher’ animals , 1999, European Neuropsychopharmacology.
[12] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[13] J. Marcilloux,et al. Stereotaxic atlas of the pig brain , 1999, Brain Research Bulletin.
[14] J. Hyttel,et al. Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[15] G. Breese,et al. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns , 1992, Brain Research.
[16] P. Plenge,et al. Regional distribution of the serotonin transport complex in human brain, identified with 3H-Paroxetine, 3H-Citalopram and 3H-Imipramine , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] A. Parent,et al. Serotoninergic innervation of the thalamus in the primate: An immunohistochemical study , 1991, The Journal of comparative neurology.
[18] A. Frazer,et al. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine , 1988, Brain Research.
[19] Peter Herscovitch,et al. The Suitability of [11C]-α-Methyl-L-tryptophan as a Tracer for Serotonin Synthesis: Studies With Dual Administration of [11C] and [14C] Labeled Tracer , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] J. Joyce,et al. Comparison of [3H]Paroxetine and [3H]Cyanoimipramine for Quantitative Measurement of Serotonin Transporter Sites in Human Brain , 1996, Neuropsychopharmacology.
[21] M. Raichle,et al. A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[22] A. Holtz,et al. Fluoxetine tenth anniversary update: the progress continues. , 1997, Clinical therapeutics.
[23] V. Pike. Positron-emitting radioligands for studies in vivo-probes for human psychopharmacology , 1993, Journal of psychopharmacology.
[24] P. Brust,et al. Radioligands for the study of the 5-HT transporter in vivo. , 1999, IDrugs : the investigational drugs journal.
[25] P. Benfield,et al. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. , 1998, Drugs.
[26] C. Nemeroff,et al. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.
[27] A. Beaudet,et al. Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine , 1981, Neuroscience.
[28] Paul Cumming,et al. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat , 1997, Brain Research.
[29] L. Descarries,et al. [3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region , 1991, Synapse.
[30] A. Gjedde,et al. Kinetics of the uptake of [3H]paroxetine in the rat brain , 1993, Synapse.